NCT02289326View on ClinicalTrials.gov

Biomarker Monitoring in TP53 Mutation Carriers

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Li-Fraumeni SyndromeHereditary Cancer SyndromesTP53 Gene Germline Mutation Carrier
Trial Locations (1)

92037

Scripps Clinic Medical Group, La Jolla

All Listed Sponsors
collaborator

J. Craig Venter Institute

OTHER

lead

Scripps Health

OTHER

NCT02289326 - Biomarker Monitoring in TP53 Mutation Carriers | Biotech Hunter | Biotech Hunter